Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

GRCL Gracell Biotechnologies Inc

10,25

0,00 (0,00%)

Zuletzt aktualisiert: 01:00:00

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Gracell Biotechnologies (NASDAQ:GRCL)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Gracell Biotechnologies Charts.

Gracell Biotechnologies (NASDAQ:GRCL)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Gracell Biotechnologies Charts.

News Gracell Biotechnologies Inc

Form 15-12G - Securities registration termination [Section 12(g)]
Montag 4 März 2024 (11 Monate vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Mittwoch 28 Februar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Montag 26 Februar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Montag 26 Februar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Montag 26 Februar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Montag 26 Februar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 22 Februar 2024 (11 Monate vor) • Edgar (US Regulatory)

Gracell Biotechnologies Acquisition Completed
Donnerstag 22 Februar 2024 (11 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 20 Februar 2024 (11 Monate vor) • Edgar (US Regulatory)

Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
Dienstag 20 Februar 2024 (11 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Mittwoch 14 Februar 2024 (11 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 30 Januar 2024 (12 Monate vor) • Edgar (US Regulatory)

Weitere Gracell Biotechnologies Inc News-Artikel

Intesa Sanpaolo

Vontobel Financial Produ...

Graniteshares 3xshort Al...

DB X-Trackers MSCI Japan...

Japan Research Enhanced ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen